Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

MDGL

Madrigal Pharmaceuticals Inc

May 14 • 12:00PM ET

539.54

+20.67 3.98 %

Healthcare • Biotechnology • USA • Large • NASD

Peers: VKTX IVA RYTM EXEL NTRA KRYS HALO CYTK CRSP BEAM

| Held by: VTI VB IWM VBK XBI VXF IBB IWO SCHA VTWO

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-12.80	Insider Own	9.14%	Shs Outstand	23.04M	Perf Week	0.87%
Market Cap	12.44B	Forward P/E	51.19	EPS next Y	10.54	Insider Trans	-5.22%	Shs Float	20.95M	Perf Month	4.04%
Enterprise Value	11.97B	PEG	-	EPS next Q	-2.38	Inst Own	102.04%	Short Float	18.40%	Perf Quarter	13.88%
Income	-309.44M	P/S	10.98	EPS this Y	49.05%	Inst Trans	1.26%	Short Ratio	11.02	Perf Half Y	-0.36%
Sales	1.13B	P/B	22.88	EPS next Y	260.99%	ROA	-27.83%	Short Interest	3.85M	Perf YTD	-7.35%
Book/sh	23.59	P/C	15.21	EPS next 5Y	-	ROE	-49.35%	52W High	615.00 -12.27%	Perf Year	90.74%
Cash/sh	35.48	P/FCF	-	EPS past 3/5Y	9.32% 0.37%	ROIC	-34.80%	52W Low	265.00 103.60%	Perf 3Y	84.19%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	92.94%	Volatility	4.75% 3.78%	Perf 5Y	300.55%
Dividend TTM	-	EV/Sales	10.57	EPS Y/Y TTM	29.06%	Oper. Margin	-27.68%	ATR (14)	22.29	Perf 10Y	3673.67%
Dividend Ex-Date	-	Quick Ratio	3.16	Sales Y/Y TTM	256.82%	Profit Margin	-27.32%	RSI (14)	58.52	Recom	1.28
Dividend Gr. 3/5Y	- -	Current Ratio	3.50	EPS Q/Q	1.93%	SMA20	3.71%	Beta	-1.06	Target Price	679.33
Payout	-	Debt/Eq	0.64	Sales Q/Q	126.84%	SMA50	8.46%	Rel Volume	0.59	Prev Close	518.87
Employees	915	LT Debt/Eq	0.64	Earnings	May 06 BMO	SMA200	12.78%	Avg Volume	349.90K	Price	539.54
IPO	Feb 06, 2007	Option/Short	Yes / Yes	EPS/Sales Surpr.	23.16% 3.42%	Trades		Volume	86,444	Change	3.98%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)